Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Nephrology
Solid organ malignancy
Questions discussed in this category
Would you recommend use of ESA for anemia of kidney disease in the setting of metastatic solid tumor malignancy?
1 Answer available
9794
Papers discussed in this category
Am J Kidney Dis, 2019 Aug 05
The Use of Erythropoiesis-Stimulating Agents in Patients With CKD and Cancer: A Clinical Approach.
Related Topics in Nephrology
Hematologic Malignancies
Radiation Oncology
Gynecologic Cancers
Genitourinary Cancers
Melanoma/Skin Cancer
Pediatric Hematology/Oncology
Prostate Cancer
Medical Oncology
Endocrine Tumors
Lymphoma